Zhejiang Orient Gene Biotech Co., Ltd (SHA:688298)

SHA:688298 Revenue

Zhejiang Orient Gene Biotech had revenue of 207.90M CNY in the quarter ending June 30, 2026, a decrease of -1.53%. This brings the company's total for the last twelve months to 1.01B, up 24.08% year-over-year. In the year 2025, Zhejiang Orient Gene Biotech had annual revenue of 947.38M with 14.43% growth. That makes Zhejiang Orient Gene Biotech the 19,574th largest company in the world by revenue and 3,573rd in China.

• Revenue (ttm): 1.01B
• Revenue Growth: +24.08%
• P/S Ratio: 3.40
• Revenue / Employee: 487.65K
• Employees: 2,068
• Market Cap: 3.43B

Revenue Chart

Chart

Chart

Revenue by Geography

Chart

• Overseas 779.98M 83.8%
• China 150.58M 16.2%

Fiscal year ended Dec 31, 2025 See the full SHA:688298 breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	947.38M	119.46M	14.43%
Dec 31, 2024	827.92M	7.76M	0.95%
Dec 31, 2023	820.16M	-7.95B	-90.65%
Dec 31, 2022	8.77B	-1.40B	-13.78%
Dec 31, 2021	10.17B	6.90B	211.43%

Data Source: S&P Global Market Intelligence Last updated: Aug 28, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 19, 2026

Data Sources Report a data error